About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of STLX-2012 in Healthy Volunteers | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingPhase 1NCT07231744

Study of STLX-2012 in Healthy Volunteers

The purpose of this research is to establish the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of a single IV dose of STLX-2012.

Lead sponsor: Stelexis BioSciences•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Clinical Trials Office

CONTACT

508-543-6979 clinicaltrials@stelexis.com

Sponsors

Lead Sponsor

Stelexis BioSciences

Age

18 - 55 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Male or female participants aged 18-55 years old, inclusive, at Screening.
•Body mass index of 18-32 kg/m\^2, inclusive
•Healthy as determined by the investigator
•Adequate hepatic and renal function
•Willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
•Male participants and females of childbearing potential must agree to use an effective method of contraception for 30 days after the last dose of STLX-2012

Exclusion Criteria

•Pregnant or lactating female.
•Positive urine drug screen or alcohol breath test
•Neutropenia, defined as neutrophil count \<2.0 x 10\^9/L
•History of allergic reaction requiring treatment or anaphylactic reactions to any therapeutic drug.
•Previous treatment with an IL-1RAP monoclonal antibody
•History of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, inflammatory, or allergic disease (excluding mild seasonal allergies)

Related studies

RECRUITINGPhase 1

A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity

NCT07310901 · Obese But Otherwise Healthy Participants

RECRUITINGPhase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

NCT06342713 · Healthy Participants, Healthy Subjects, and more

Evaluation of Muscle Oxygenation and Recovery Dynamics in Individuals With Knee Osteoarthritis

NCT07471204 · Osteoarthritis of Knee, Healthy Participants

RECRUITINGPhase 1

Study of BW-50218 in Healthy Participants

NCT07401472 · Healthy Participants Study

RECRUITINGPhase 1

A Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2085

NCT07412353 · Healthy Participants

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 22, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhasePHASE1

Enrollment32

Start dateOct 2026

Last updatedApr 22, 2026

Condition

Healthy Participants

Locations shown

Nucleus Network Brisbane

Brisbane, Queensland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 22, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions